Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss

• Autorzy: Talar-Wojnarowska R. , Wozniak M. , Borkowska A. , Olakowski M. , Malecka-Panas E.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

adenocarcinoma; pancreatic ductal adenocarcinoma; weight loss; cytokine; activin A; myostatin; ligand; transforming growth factor-beta; muscle cachexia; C-reactive protein

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2020
• Tom: 71
• Numer: 1
• Opis fizyczny: p.105-112,fig.,ref.

Twórcy

autor

Talar-Wojnarowska R.

• Department of Digestive Tract Diseases, Medical University of Lodz, 22 Kopcinskiego Street, 91-425 Lodz, Poland

autor

Wozniak M.

• Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland

autor

Borkowska A.

• Department of Internal Diseases and Diabetology, Medical University of Lodz, Lodz, Poland

autor

Olakowski M.

• Department of Digestive Tract Surgery, Silesian Medical University, Katowice, Poland

autor

Malecka-Panas E.

• Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland

Identyfikatory

DOI

10.26402/jpp.2020.1.10